Insider filing · MDGL
David Soergel
Chief Medical Officer
profile →
Madrigal Pharmaceuticals, Inc.
MDGL · Healthcare · 59 filings in 24 months
ticker →
David Soergel sold $435K of Madrigal Pharmaceuticals (MDGL)
Executed May 18, disclosed May 18, the same day.
Value, as filed
$435K
844 sh × $515.90
Executed
May 18
the trade date, as filed
Disclosed
May 18
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
DSDavid Soergel (Chief Medical Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Madrigal Pharmaceuticals, Inc. (MDGL). The largest single filing was $517K of MDGL (1,042 sh × $495.74, as filed), executed Jun 1.
The name
MDGLHealthcare · Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by David Soergel in MDGL
MDGLSALE
Madrigal Pharmaceuticals, Inc.
$517K1,042 sh × $495.74
Exec Jun 1
Filed Jun 1 · 5:30 PM ET